Options Brief: Seattle Genetics

Shares of Seattle Genetics SGEN are lower on the session by 0.39%, trading at $20.55. Overall put volume is now running at 5.48x the daily average, with 0% of all puts traded being purchases on the offer. 1,748 contracts have traded on the session so far. Seattle Genetics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for cancer and autoimmune diseases.